Clinical Trials Logo
  1. Home
  2. Opioid-induced Constipation
  3. NCT01117051

Prucalopride Effects on Subjects With Chronic Non-cancer Pain Suffering From Opioid Induced Constipation — OIC  

Opioid Induced Constipation Clinical Trial

Official title:
A 12-week, Randomised, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy and Safety of Prucalopride in Subjects With Chronic Non-cancer Pain Suffering From Opioid Induced Constipation

Clinical Trial Summary

The study will evaluate the efficacy, safety and tolerability of prucalopride over 12 weeks of treatment in subjects aged 18 years and older with chronic non-cancer pain, suffering from opioid induced constipation.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT01117051
Study type Interventional
Source Takeda
Contact
Status Terminated
Phase Phase 3
Start date May 19, 2010
Completion date August 13, 2012
View Details
See also
  Status Clinical Trial Phase
Terminated NCT02813369 - Naloxegol Health Outcome Post Authorisation Safety Study
Completed NCT01957046 - A Single-arm, Study to Assess the Effect and Tolerability of Standardised Laxative Therapy (SLT) for the Reversal of Opioid-induced Constipation (OIC). Phase 4
Completed NCT01401985 - A Study of TD-1211 in Subjects With Opioid-Induced Constipation (OIC) Phase 2
Completed NCT00984334 - Naloxone SR Capsules in Patients With Opioid Induced Constipation Phase 2
Completed NCT01207427 - Evaluation of the Efficacy and Safety of ADL5945 for the Treatment of Opioid-induced Constipation in Adults Taking Opioid Therapy for Chronic Noncancer Pain Phase 2
Completed NCT01459926 - A Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Efficacy of TD-1211 in Subjects With Opioid-Induced Constipation Phase 2
Completed NCT03060512 - To Evaluate Patient Preference of Movantik and Polyethylene Glycol 3350 for Opioid Induced Constipation Phase 4
Completed NCT01109511 - A Comparison of Oxycodone/Naloxone and Oxycodone After Laparoscopic Hysterectomy Phase 4
Active, not recruiting NCT02813356 - Naloxegol US PMR CV Safety.
Completed NCT01812733 - Non-interventional Study Comparing Targiniq and Oxycodone/Laxatives N/A
Completed NCT01623609 - Open Label, Healthy Volunteers, Bioequivalence Study With Naloxegol Phase 1
Completed NCT02813148 - Naloxegol Drug Utilization Post Authorisation Safety Study
Completed NCT01443403 - A Study of S-297995 for the Treatment of Opioid-Induced Constipation in Subjects With Non-Malignant Chronic Pain Receiving Opioid Therapy Phase 2
Completed NCT03638440 - Real World Observational Study of Naloxegol for Patients With Cancer Pain Diagnosed With OIC.